CAH · 10-Q · 2026Q3 · Full report

Segment Profitability

CARDINAL HEALTH INC · 2026-11-05 · Importance 41 · Surprise 48

Pharmaceutical and Specialty Solutions segment profit increased 17% year over year to $783 million, reflecting increased contributions from branded and specialty pharmaceutical products and the generics program. Global Medical Products and Distribution segment profit decreased 28% to $33 million because of unfavorable distribution and foreign exchange impacts, partly offset by Cardinal Health brand growth. Other segment profit rose 16% to $193 million, driven by OptiFreight Logistics, Nuclear and Precision Health Solutions, and at-Home Solutions.

Key facts

• GMPD segment profit decreased 28% year over year to $33 million, primarily due to unfavorable distribution and foreign exchange impacts, partially offset by Cardinal Health brand growth. source
• Pharma segment profit increased 17% year over year to $783 million, primarily due to increased branded and specialty pharmaceutical contributions and generics program performance. source
• Other segment profit increased 16% year over year to $193 million due to OptiFreight Logistics, Nuclear and Precision Health Solutions, and at-Home Solutions performance. source